Trial Opportunities

Akili Achieves Primary Efficacy Endpoint in Pediatric ADHD Pivotal Trial

Company Completes Large Multi-Center, Randomized, Controlled Study of Novel Digital Medicine and Plans Regulatory Filing   BOSTON, Mass – December 4, 2017 – Akili Interactive (“Akili” or “Company”), an affiliate of PureTech Health (PRTC.L), today announced top-line results from the Company’s STARS-ADHD pivotal study of its lead investigational digital medicine, AKL-T01, in pediatric attention-deficit/hyperactivity disorder (ADHD). In a randomized, […]

Summer 2017 Updates

New Clinical Trials for Summer 2017 ADHD A new study for kids – ages 8-12 – with ADHD. The study is using an at home game-based digital therapy for treating pediatric ADHD symptoms. Enrollment is expected to go very quickly and may have only 4 weeks to enroll eligible participants. Alzheimer’s (early detection) A clinical […]

Fall 2016 Updates

Hello! Just a few updates for the Fall 2016 season with new studies added and a community event coming up. If you have any questions or would like more information about a study, contact us at 405-235-8188 or by email at Walk To End Alzheimer’s 2016 Come out and join us as we support the […]

Summer 2016 Updates

New Clinical Trials for Summer 2016 Hello everyone! We will be starting enrollment on a few new clinical trials and will be wrapping up enrollment with others. Below is an update on the various study openings and closings. If you would like to sign up to participate, fill out a trial application or contact us […]

Help Make a Difference

Let’s start by playing a word game! I’m going to type a word and I want you to say the first word that pops into your head. Are you ready? Okay then, here we go… Alzheimer’s. What word popped into your head? Grandmother? Grandfather? Maybe it was Dad or Mom? Or maybe it was husband […]

Winter 2016 Updates

Happy New Year! Here is a quick update to keep you informed on our new trial opportunities for 2016. New Study Openings Alzheimer’s Disease (ages 50+) Binge Eating Disorder (ages 18-55) COPD (ages 40+) Depression (ages 18-75) Kids ADHD (ages 6-12) Migraines (ages 18-75) These studies are all open for enrollment as of today. If you […]

Food Safety Tips for the Holidays

If you’re from a large family or you like to host big parties, you are probably very familiar with a buffet style meal and all the effort it takes to get everything on the table only to find out that some of your guests haven’t arrived. Most people use the “too bad, so sad” mentality […]

Diet and Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of death globally and in the US. Over 120,000 people die of COPD ever year in the US. It is not just a smoker disease, 10-20% of COPD patients have never smoked (View COPD Fact Sheet). IPS is dedicated to finding new ways to prevent, treat, and […]

Upcoming Trial Opportunities

We will be opening many new studies over the next coming weeks. Below is a short summary of all our new trials. For a complete listing as well as additional information and eligiblilty requirements, visit our Trial Opportunities page. Adult ADHD Alzheimer’s Asthma Binge Eating COPD Depression Irritable Bowl Syndrome (IBS) Migraines If you have […]

A New Era Has Arrived

Today marks a special day for IPS Research.  Over the past 3 months, we have been working with Robot House Creative to update our logo and website to better reflect who we are and what we are about. It has been a process that has made us reflect on our identity, values, and direction as a […]

Walk to End Alzheimer’s

Our IPS team had a blast at this year’s Walk to End Alzheimer’s. It was a beautiful morning with perfect weather. The crowd was large and energetic. A big thank you to the Alzheimer’s Association and everyone who helped to organize this event. We appreciate all who came out to show support for Alzheimer’s research. […]